In Search of an Optimal Model for the Legal Regulation of Neurogenetics in the Russian Federation

Neurogenetics is a rapidly developing field of genetics that is important for the diagnosis, treatment, and prevention of neurological disorders. The paper scrutinizes the legal aspects of neurogenetics related to the procedure for conducting neurogenetic testing and the use of its results for the development of personalized medicine. The author analyzes the types of neurogenetic testing, problematic issues of obtaining informed consent, and conducting non-invasive prenatal testing. According to the author, the potential use of neurogenetics directly depends on proper legal regulation of the procedure for conducting neurogenetic testing, which may be helpful in identifying specific genetic mutations associated with the occurrence of neurological disorders. However, many aspects of neurogenetic testing, including confidentiality, genetic discrimination, and the procedure for reporting test results, require legislative regulation. Adequate legal regulation will enable the full potential of neurogenetic testing, including the latest diagnostic, preventative, and clinical tools tailored to individual neurogenetic profiles. Regulatory guidance on the use of neurogenetics will facilitate increased access to neurogenetic testing and treatment, which are critical to reducing the burden of neurological disorders.